about
Risks of Antibiotic Exposures Early in Life on the Developing MicrobiomeEarly Life Factors Influencing the Risk of ObesityLessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in PediatricsNew Molecular Techniques to Study the Skin Microbiota of Diabetic Foot UlcersBrain-gut microbiome interactions and functional bowel disordersProbiotics and necrotizing enterocolitisMobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genesHealthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical AnalysisThe Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of ChildhoodRole of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the LiteratureAntibiotics, pediatric dysbiosis, and diseaseThe infant gut microbiome: evidence for obesity risk and dietary interventionGut Microbiome and Obesity: A Plausible Explanation for ObesityAssociation of caesarean delivery with child adiposity from age 6 weeks to 15 yearsHuman microbiome science: vision for the future, Bethesda, MD, July 24 to 26, 2013Replenishing our defensive microbesProbiotics, prebiotics, and the host microbiome: the science of translationAltering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic ConsequencesDevelopmental origins of type 2 diabetes: a perspective from ChinaSimulated Conversations With Virtual Humans to Improve Patient-Provider Communication and Reduce Unnecessary Prescriptions for Antibiotics: A Repeated Measure Pilot Study.The gut microbiome in cardio-metabolic health.Irrational use of antibiotics and the risk of diabetes in GhanaA novel role for maternal stress and microbial transmission in early life programming and neurodevelopment.Early Antibiotic Exposure in Low-Resource Settings is Associated with Increased Weight in The First Two Years of Life.Early-Life Host-Microbiome Interphase: The Key Frontier for Immune DevelopmentAntibiotics modulate intestinal immunity and prevent necrotizing enterocolitis in preterm neonatal pigletsBugs, guts and brains, and the regulation of food intake and body weightMicrobial 'old friends', immunoregulation and socioeconomic status.Population-based cohort study of anti-infective medication use before and after the onset of type 1 diabetes in children and adolescents.Quantifying the metabolic activities of human-associated microbial communities across multiple ecological scales.Diversity and composition of the adult fecal microbiome associated with history of cesarean birth or appendectomy: Analysis of the American Gut Project.Research on neonatal microbiomes: what neonatologists need to know.Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus.Modulation of gut microbiota in the management of metabolic disorders: the prospects and challengesLife at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease.Allergic inflammation--innately homeostaticInfant antibiotic exposure and the development of childhood overweight and central adiposity.Gut microbiota, the immune system, and diet influence the neonatal gut-brain axis.Prenatal exposure to antibiotics, cesarean section and risk of childhood obesityAntibiotics in early life and obesity.
P2860
Q21131324-42668F1E-172C-4944-85FB-543EDA5FE9BFQ26771782-1EB70DAA-6FC1-47BB-AF00-D1A1A73C3B06Q26781072-B05A9A26-D30C-44B7-BFFE-5CDE035C8D0AQ26862785-05BD56C5-8393-4194-866D-C74C2BF567CFQ27014531-3C1289C4-BF0D-432C-931B-C33FC240549EQ27015119-95B88820-1CB9-4FB7-93AC-FF87EA448921Q27030750-29819D60-59DB-4752-AE3D-C3F056379350Q27968225-F81334B1-C863-4F6B-B1BF-79E36CFBAB20Q28075770-F1F3EA3E-6AD3-42CE-9E46-D69B2168A755Q28079131-C6AFFDDE-202E-4EFF-A2AB-807B30BB2F7BQ28080536-4D5BADE8-7059-47A6-A2A6-7E3936B4332BQ28084387-62937CAC-4DDB-4917-B988-8BF8469E2664Q28087145-0F42A374-6754-4B2B-AC29-7110E5F1353EQ28596458-7AF56C69-3346-4F51-B166-1073F69095BBQ28655573-96D00A06-63E1-4A5E-B3DA-6808E03D9688Q28655590-EF950249-6B56-46FE-9AD0-125E8FF2BF5CQ28657826-D40CADF8-92C4-444D-8622-6085E9424E1AQ29394736-99B92D6C-AA6A-46C1-AC2A-3E7643C387FBQ29994665-313C8F9E-74D5-4E46-B881-DF1E9235A4D2Q30148713-54B240B0-0735-4F7B-9C7E-1391F88C732DQ30373247-2E723628-D0E7-456B-A25E-8E4C731942F3Q30393011-384FD843-CCF0-40CA-AF65-19D1882F6FF3Q30394981-DA77CF2A-3BA9-4D8E-B065-D789364229E3Q30491976-F3B9D93D-0E3E-4523-A245-20C9D554D22EQ33720577-BC9BFB11-BE8E-4115-8F8A-11161BAA8B22Q33816538-003E120B-CA4E-4B4F-AF2C-04C5DFA8323BQ33838142-92367EF2-EFC2-4CB0-9957-4A79C30C499DQ33871387-27AFF859-E54E-49F0-802D-B12C8C104F72Q34058260-03DB1D78-125C-4CB3-BF6A-DE3104F051E1Q34646255-074C3952-9408-487C-927F-7C800A009E89Q34976762-3BF77311-06E8-464A-B993-E19AA8DA27CEQ35032072-532C307F-94D9-4D52-9836-A31375E1444FQ35094314-E13B946E-73D7-4142-BE25-7EBE9FC54A30Q35114851-C7A2D241-AA71-40BD-8D17-EE421A1C58B1Q35124886-5533F098-9D67-4387-9FF9-020A97B7F159Q35164318-A4CE1318-1942-4979-8168-5E7C86D40398Q35205002-C82604BD-F4A2-4AB3-A805-DFABC132E8C9Q35320851-2162FAF6-BF31-49E6-871F-D7CBE956A9C7Q35328729-82039000-8105-481C-AB16-67DA37D5D19BQ35501942-A46BE506-DE4D-4A25-933E-ACF595F29D91
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Infant antibiotic exposures and early-life body mass
@ast
Infant antibiotic exposures and early-life body mass
@en
Infant antibiotic exposures and early-life body mass
@nl
type
label
Infant antibiotic exposures and early-life body mass
@ast
Infant antibiotic exposures and early-life body mass
@en
Infant antibiotic exposures and early-life body mass
@nl
prefLabel
Infant antibiotic exposures and early-life body mass
@ast
Infant antibiotic exposures and early-life body mass
@en
Infant antibiotic exposures and early-life body mass
@nl
P2093
P2860
P356
P1476
Infant antibiotic exposures and early-life body mass
@en
P2093
P2860
P2888
P356
10.1038/IJO.2012.132
P407
P577
2012-08-21T00:00:00Z
P5875
P6179
1012425643